866-997-4948(US-Canada Toll Free)

Global and United States Drugs for Malaria In-Depth Research Report 2017-2022

Published By :

US Market Insight

Published Date : Dec 2017

Category :

Pharmaceutical

No. of Pages : 103 Pages

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Drugs for Malaria industry.

Major Companies
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi?Aventis
Ajanta Pharma

Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main types of products
Drugs for Malaria Market, byyl Aminoalcohol Compounds
Drugs for Malaria Market, bytifolate Compounds
Drugs for Malaria Market, bytemisinin Compounds

Drugs for Malaria Market, by Key Consumers
Prevention
Treatment
Other

Table of Contents

Global and United States Drugs for Malaria In-Depth Research Report 2017-2022
Chapter One Global Drugs for Malaria Market Overview
1.1 Global Drugs for Malaria Market Sales Volume Revenue and Price 2012-2017
1.2 Drugs for Malaria, by l Aminoalcohol Compounds 2012-2017
1.2.1 Global Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds 2012-2017
1.2.2 Global Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds 2012-2017
1.2.3 Global Drugs for Malaria Price by l Aminoalcohol Compounds 2012-2017
1.2.4
1.2.5
1.3 Drugs for Malaria, by ifolate Compounds 2012-2017
1.3.1 Global Drugs for Malaria Sales Market Share by ifolate Compounds 2012-2017
1.3.2 Global Drugs for Malaria Revenue Market Share by ifolate Compounds 2012-2017
1.3.3 Global Drugs for Malaria Price by ifolate Compounds 2012-2017
1.3.4
1.3.5
1.4 Drugs for Malaria, by emisinin Compounds 2012-2017
1.4.1 Global Drugs for Malaria Sales Market Share by emisinin Compounds 2012-2017
1.4.2 Global Drugs for Malaria Revenue Market Share by emisinin Compounds 2012-2017
1.4.3 Global Drugs for Malaria Price by emisinin Compounds 2012-2017
1.4.4
1.4.5

Chapter Two United States Drugs for Malaria Market Overview
2.1 United States Drugs for Malaria Market Sales Volume Revenue and Price 2012-2017
2.2 Drugs for Malaria, by l Aminoalcohol Compounds 2012-2017
2.2.1 United States Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds 2012-2017
2.2.2 United States Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds 2012-2017
2.2.3 United States Drugs for Malaria Price by l Aminoalcohol Compounds 2012-2017
2.2.4
2.2.5
2.3 Drugs for Malaria, by ifolate Compounds 2012-2017
2.3.1 United States Drugs for Malaria Sales Market Share by ifolate Compounds 2012-2017
2.3.2 United States Drugs for Malaria Revenue Market Share by ifolate Compounds 2012-2017
2.3.3 United States Drugs for Malaria Price by ifolate Compounds 2012-2017
2.3.4
2.3.5
2.4 Drugs for Malaria, by emisinin Compounds 2012-2017
2.4.1 United States Drugs for Malaria Sales Market Share by emisinin Compounds 2012-2017
2.4.2 United States Drugs for Malaria Revenue Market Share by emisinin Compounds 2012-2017
2.4.3 United States Drugs for Malaria Price by emisinin Compounds 2012-2017
2.4.4
2.4.5

Chapter Three Drugs for Malaria by Regions 2012-2017
3.1 Global Drugs for Malaria Sales Market Share by Regions 2012-2017
3.2 Global Drugs for Malaria Revenue Market Share by Regions 2012-2017
3.3 Global Drugs for Malaria Price by Regions 2012-2017
3.4 North America
3.4.1 United States
3.4.1.1 California
3.4.1.2 Texas
3.4.1.3 New York
3.4.1.4 Others in United States
3.4.2 Canada
3.5 Latin America
3.5.1 Mexico
3.5.2 Brazil
3.5.3 Argentina
3.5.4 Others in Latin America
3.6 Europe
3.6.1 Germany
3.6.2 United Kingdom
3.6.3 France
3.6.4 Italy
3.6.5 Spain
3.6.6 Russia
3.6.7 Netherland
3.6.8 Others in Europe
3.7 Asia & Pacific
3.7.1 China
3.7.2 Japan
3.7.3 India
3.7.4 Korea
3.7.5 Australia
3.7.6 Southeast Asia
3.7.6.1 Indonesia
3.7.6.2 Thailand
3.7.6.3 Philippines
3.7.6.4 Vietnam
3.7.6.5 Singapore
3.7.6.6 Malaysia
3.7.6.7 Others in Southeast Asia
3.8 Africa & Middle East
3.8.1 South Africa
3.8.2 Egypt
3.8.3 Turkey
3.8.4 Saudi Arabia
3.8.5 Iran
3.8.6 Others in Africa & Middle East

Chapter Four Global Drugs for Malaria by Companies 2012-2017
4.1 Global Drugs for Malaria Sales Volume Market Share by Companies 2012-2017
4.2 Global Drugs for Malaria Revenue Share by Companies 2012-2017
4.3 Global Top Companies Drugs for Malaria Key Product Model and Market Performance
4.4 Global Top Companies Drugs for Malaria Key Target Consumers and Market Performance

Chapter Five United States Drugs for Malaria by Companies 2012-2017
5.1 United States Drugs for Malaria Sales Volume Market Share by Companies 2012-2017
5.2 United States Drugs for Malaria Revenue Share by Companies 2012-2017
5.3 United States Top Companies Drugs for Malaria Key Product Model and Market Performance
5.4 United States Top Companies Drugs for Malaria Key Target Consumers and Market Performance

Chapter Six Global Drugs for Malaria by Consumer 2012-2017
6.1 Global Drugs for Malaria Sales Market Share by Consumer 2012-2017
6.2 Prevention
6.3 Treatment
6.4 Other
6.5 Consuming Habit and Preference

Chapter Seven Global Drugs for Malaria by Consumer 2012-2017
7.1 Global Drugs for Malaria Sales Market Share by Consumer 2012-2017
7.2 Prevention
7.3 Treatment
7.4 Other
7.5 Consuming Habit and Preference

Chapter Eight Top Companies Profile
8.1 Cipla
8.1.1 Cipla Company Details and Competitors
8.1.2 Cipla Key Drugs for Malaria Models and Performance
8.1.3 Cipla Drugs for Malaria Business SWOT Analysis and Forecast
8.1.4 Cipla Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.2 Guilin Pharmaceutical
8.2.1 Guilin Pharmaceutical Company Details and Competitors
8.2.2 Guilin Pharmaceutical Key Drugs for Malaria Models and Performance
8.2.3 Guilin Pharmaceutical Drugs for Malaria Business SWOT Analysis and Forecast
8.2.4 Guilin Pharmaceutical Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.3 IPCA Laboratories
8.3.1 IPCA Laboratories Company Details and Competitors
8.3.2 IPCA Laboratories Key Drugs for Malaria Models and Performance
8.3.3 IPCA Laboratories Drugs for Malaria Business SWOT Analysis and Forecast
8.3.4 IPCA Laboratories Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.4 GlaxoSmithKline
8.4.1 GlaxoSmithKline Company Details and Competitors
8.4.2 GlaxoSmithKline Key Drugs for Malaria Models and Performance
8.4.3 GlaxoSmithKline Drugs for Malaria Business SWOT Analysis and Forecast
8.4.4 GlaxoSmithKline Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.5 Mylan Labs
8.5.1 Mylan Labs Company Details and Competitors
8.5.2 Mylan Labs Key Drugs for Malaria Models and Performance
8.5.3 Mylan Labs Drugs for Malaria Business SWOT Analysis and Forecast
8.5.4 Mylan Labs Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.6 Roche
8.6.1 Roche Company Details and Competitors
8.6.2 Roche Key Drugs for Malaria Models and Performance
8.6.3 Roche Drugs for Malaria Business SWOT Analysis and Forecast
8.6.4 Roche Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.7 Novartis
8.7.1 Novartis Company Details and Competitors
8.7.2 Novartis Key Drugs for Malaria Models and Performance
8.7.3 Novartis Drugs for Malaria Business SWOT Analysis and Forecast
8.7.4 Novartis Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.8 Sanofi?Aventis
8.8.1 Sanofi?Aventis Company Details and Competitors
8.8.2 Sanofi?Aventis Key Drugs for Malaria Models and Performance
8.8.3 Sanofi?Aventis Drugs for Malaria Business SWOT Analysis and Forecast
8.8.4 Sanofi?Aventis Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin
8.9 Ajanta Pharma
8.9.1 Ajanta Pharma Company Details and Competitors
8.9.2 Ajanta Pharma Key Drugs for Malaria Models and Performance
8.9.3 Ajanta Pharma Drugs for Malaria Business SWOT Analysis and Forecast
8.9.4 Ajanta Pharma Drugs for Malaria Sales Volume Revenue Price Cost and Gross Margin

Chapter Nine Industry Chain and Supply Chain
9.1 Drugs for Malaria Industry Chain Structure
9.1.1 R&D
9.1.2 Raw Materials (Components)
9.1.3 Manufacturing Plants
9.1.4 Regional Trading (Import Export and Local Sales)
9.1.5 Online Sales Channel
9.1.6 Offline Channel
9.1.7 End Users
9.2 Drugs for Malaria Manufacturing
9.2.1 Key Components
9.2.2 Assembly Manufacturing
9.3 Consumer Preference
9.4 Behavioral Habits
9.5 Marketing Environment

Chapter Ten Global Drugs for Malaria Market Size (Sales and Revenue) Forecast (2017-2022)
10.1 Global Drugs for Malaria Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
10.2 Global Drugs for Malaria Sales (K Pcs) Forecast by Regions (2017-2022)
10.3 Global Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
10.4 Global Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
10.5 Global Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
10.6 Global Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)

Chapter Eleven United States Drugs for Malaria Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 United States Drugs for Malaria Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 United States Drugs for Malaria Sales (K Pcs) Forecast by Regions (2017-2022)
11.3 United States Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
11.4 United States Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
11.5 United States Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
11.6 United States Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)

Chapter Twelve Development Trend and Research Conclusion
12.1 Development Trend
12.2 Research Conclusion

Chapter Thirteen Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Table Global Drugs for Malaria Sales Volume (K Pcs), Revenue (Million USD) and Price (USD/Pcs)(2012-2017)
Figure Global Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Drugs for Malaria Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table Global Drugs for Malaria Sales (K Pcs) by l Aminoalcohol Compounds (2012-2017)
Table Global Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds in 2016
Table Global Drugs for Malaria Revenue (Million USD) by l Aminoalcohol Compounds (2012-2017)
Table Global Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds (2012-2017)
Figure Global Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds in 2016
Table Global Drugs for Malaria Price (USD/Pcs) by l Aminoalcohol Compounds (2012-2017)
Table Global Drugs for Malaria Sales (K Pcs) by ifolate Compounds (2012-2017)
Table Global Drugs for Malaria Sales Market Share by ifolate Compounds (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by ifolate Compounds in 2016
Table Global Drugs for Malaria Revenue (Million USD) by ifolate Compounds (2012-2017)
Table Global Drugs for Malaria Revenue Market Share by ifolate Compounds (2012-2017)
Figure Global Drugs for Malaria Revenue Market Share by ifolate Compounds in 2016
Table Global Drugs for Malaria Price (USD/Pcs) by ifolate Compounds (2012-2017)
Table Global Drugs for Malaria Sales (K Pcs) by emisinin Compounds (2012-2017)
Table Global Drugs for Malaria Sales Market Share by emisinin Compounds (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by emisinin Compounds in 2016
Table Global Drugs for Malaria Revenue (Million USD) by emisinin Compounds (2012-2017)
Table Global Drugs for Malaria Revenue Market Share by emisinin Compounds (2012-2017)
Figure Global Drugs for Malaria Revenue Market Share by emisinin Compounds in 2016
Table Global Drugs for Malaria Price (USD/Pcs) by emisinin Compounds (2012-2017)
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Drugs for Malaria Sales Volume (K Pcs) and Growth Rate (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by l Aminoalcohol Compounds (2012-2017)
Table United States Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by l Aminoalcohol Compounds in 2016
Table United States Drugs for Malaria Revenue (Million USD) by l Aminoalcohol Compounds (2012-2017)
Table United States Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by l Aminoalcohol Compounds in 2016
Table United States Drugs for Malaria Price (USD/Pcs) by l Aminoalcohol Compounds (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by ifolate Compounds (2012-2017)
Table United States Drugs for Malaria Sales Market Share by ifolate Compounds (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by ifolate Compounds in 2016
Table United States Drugs for Malaria Revenue (Million USD) by ifolate Compounds (2012-2017)
Table United States Drugs for Malaria Revenue Market Share by ifolate Compounds (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by ifolate Compounds in 2016
Table United States Drugs for Malaria Price (USD/Pcs) by ifolate Compounds (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by emisinin Compounds (2012-2017)
Table United States Drugs for Malaria Sales Market Share by emisinin Compounds (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by emisinin Compounds in 2016
Table United States Drugs for Malaria Revenue (Million USD) by emisinin Compounds (2012-2017)
Table United States Drugs for Malaria Revenue Market Share by emisinin Compounds (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by emisinin Compounds in 2016
Table United States Drugs for Malaria Price (USD/Pcs) by emisinin Compounds (2012-2017)
Table Global Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table Global Drugs for Malaria Sales Share by Regions (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by Regions in 2016
Figure Global Drugs for Malaria Sales Market Share by Regions in 2017
Table Global Drugs for Malaria Revenue (Million USD) and Market Share by Regions (2012-2017)
Table Global Drugs for Malaria Revenue Market Share by Regions (2012-2017)
Figure Global Drugs for Malaria Revenue Market Share by Regions in 2016
Figure Global Drugs for Malaria Revenue Market Share by Regions in 2017
Table Global Drugs for Malaria Price (USD/Pcs) by Regions (2012-2017)
Table North America Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table North America Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure North America Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table United States Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure United States Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Latin America Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table Latin America Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure Latin America Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Europe Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table Europe Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure Europe Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Asia & Pacific Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table Asia & Pacific Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure Asia & Pacific Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Africa & Middle East Drugs for Malaria Sales (K Pcs) by Regions (2012-2017)
Table Africa & Middle East Drugs for Malaria Revenue (Million USD) by Regions (2012-2017)
Figure Africa & Middle East Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Global Drugs for Malaria Sales Volume (K Pcs) by Major Companies (2012-2017)
Table Global Drugs for Malaria Sales Volume Market Share by Major Companies (2012-2017)
Figure Global Drugs for Malaria Sales Volume Market Share by Major Companies 2016
Figure Global Drugs for Malaria Sales Volume Market Share by Major Companies 2017
Table Global Drugs for Malaria Revenue (Million USD) by Major Companies (2012-2017)
Table Global Drugs for Malaria Revenue Market Share by Major Companies (2012-2017)
Figure Global Drugs for Malaria Revenue Market Share by Major Companies 2016
Figure Global Drugs for Malaria Revenue Market Share by Major Companies 2017
Table Global Top Companies Key Product Model and Market Performance
Table Global Top Companies Key Target Consumers and Market Performance
Table United States Drugs for Malaria Sales Volume (K Pcs) by Top Companies (2012-2017)
Table United States Drugs for Malaria Sales Volume Market Share by Top Companies (2012-2017)
Figure United States Drugs for Malaria Sales Volume Market Share by Top Companies 2016
Figure United States Drugs for Malaria Sales Volume Market Share by Top Companies 2017
Table United States Drugs for Malaria Revenue (Million USD) by Top Companies (2012-2017)
Table United States Drugs for Malaria Revenue Market Share by Top Companies (2012-2017)
Figure United States Drugs for Malaria Revenue Market Share by Top Companies 2016
Figure United States Drugs for Malaria Revenue Market Share by Top Companies 2017
Table United States Top Companies Key Product Model and Market Performance
Table United States Top Companies Key Target Consumers and Market Performance
Table Global Drugs for Malaria Sales (K Pcs) by Consumer (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by Consumer (2012-2017)
Figure Global Drugs for Malaria Sales Market Share by Consumer in 2016
Figure Global Prevention Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Treatment Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Figure Global Other Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table United States Drugs for Malaria Sales (K Pcs) by Consumer (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Consumer (2012-2017)
Figure United States Drugs for Malaria Sales Market Share by Consumer in 2016
Figure United States Prevention Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Treatment Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Other Drugs for Malaria Sales (K Pcs) and Growth Rate (2012-2017)
Table Cipla Company Details and Competitors
Table Cipla Key Drugs for Malaria Models and Performance
Table Cipla Drugs for Malaria Business SWOT Analysis and Forecast
Table Cipla Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Cipla Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Cipla Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Cipla Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Cipla Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Guilin Pharmaceutical Company Details and Competitors
Table Guilin Pharmaceutical Key Drugs for Malaria Models and Performance
Table Guilin Pharmaceutical Drugs for Malaria Business SWOT Analysis and Forecast
Table Guilin Pharmaceutical Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table IPCA Laboratories Company Details and Competitors
Table IPCA Laboratories Key Drugs for Malaria Models and Performance
Table IPCA Laboratories Drugs for Malaria Business SWOT Analysis and Forecast
Table IPCA Laboratories Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure IPCA Laboratories Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table GlaxoSmithKline Company Details and Competitors
Table GlaxoSmithKline Key Drugs for Malaria Models and Performance
Table GlaxoSmithKline Drugs for Malaria Business SWOT Analysis and Forecast
Table GlaxoSmithKline Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Mylan Labs Company Details and Competitors
Table Mylan Labs Key Drugs for Malaria Models and Performance
Table Mylan Labs Drugs for Malaria Business SWOT Analysis and Forecast
Table Mylan Labs Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Mylan Labs Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Mylan Labs Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Roche Company Details and Competitors
Table Roche Key Drugs for Malaria Models and Performance
Table Roche Drugs for Malaria Business SWOT Analysis and Forecast
Table Roche Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Roche Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Roche Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Roche Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Roche Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Novartis Company Details and Competitors
Table Novartis Key Drugs for Malaria Models and Performance
Table Novartis Drugs for Malaria Business SWOT Analysis and Forecast
Table Novartis Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Novartis Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Novartis Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Novartis Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Novartis Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Sanofi?Aventis Company Details and Competitors
Table Sanofi?Aventis Key Drugs for Malaria Models and Performance
Table Sanofi?Aventis Drugs for Malaria Business SWOT Analysis and Forecast
Table Sanofi?Aventis Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Sanofi?Aventis Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Table Ajanta Pharma Company Details and Competitors
Table Ajanta Pharma Key Drugs for Malaria Models and Performance
Table Ajanta Pharma Drugs for Malaria Business SWOT Analysis and Forecast
Table Ajanta Pharma Drugs for Malaria Output (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales (Million Unit) and Growth Rate (%)(2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Market Share (%) in Global (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)
Figure Ajanta Pharma Drugs for Malaria Revenue Market Share (%) in Global (2012-2017)
Figure Global Drugs for Malaria Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure Global Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Drugs for Malaria Price (USD/Pcs) Trend Forecast (2017-2022)
Table Global Drugs for Malaria Sales (K Pcs) Forecast by Regions (2017-2022)
Table Global Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Drugs for Malaria Sales Volume Share Forecast by Regions in 2022
Table Global Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Drugs for Malaria Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Drugs for Malaria Sales Volume Market Share Forecast by Application in 2022
Table Global Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
Figure Global Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
Figure Global Drugs for Malaria Sales Volume Market Share Forecast by l Aminoalcohol Compounds in 2022
Table Global Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
Figure Global Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
Figure Global Drugs for Malaria Sales Volume Market Share Forecast by ifolate Compounds in 2022
Table Global Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)
Figure Global Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)
Figure Global Drugs for Malaria Sales Volume Market Share Forecast by emisinin Compounds in 2022
Figure United States Drugs for Malaria Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Malaria Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Drugs for Malaria Sales (K Pcs) Forecast by Regions (2017-2022)
Table United States Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Drugs for Malaria Sales Volume Share Forecast by Regions (2017-2022)
Figure United States Drugs for Malaria Sales Volume Share Forecast by Regions in 2022
Table United States Drugs for Malaria Sales (K Pcs) Forecast by Application (2017-2022)
Figure United States Drugs for Malaria Sales Volume Market Share Forecast by Application (2017-2022)
Figure United States Drugs for Malaria Sales Volume Market Share Forecast by Application in 2022
Table United States Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
Figure United States Drugs for Malaria Sales (K Pcs) Forecast by l Aminoalcohol Compounds (2017-2022)
Figure United States Drugs for Malaria Sales Volume Market Share Forecast by l Aminoalcohol Compounds in 2022
Table United States Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
Figure United States Drugs for Malaria Sales (K Pcs) Forecast by ifolate Compounds (2017-2022)
Figure United States Drugs for Malaria Sales Volume Market Share Forecast by ifolate Compounds in 2022
Table United States Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)
Figure United States Drugs for Malaria Sales (K Pcs) Forecast by emisinin Compounds (2017-2022)
Figure United States Drugs for Malaria Sales Volume Market Share Forecast by emisinin Compounds in 2022

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *